If ever a modality was all things to all people, that modality is ultrasound. Just about the only specialty these days not using a form of noninvasive ultrasound is plastic surgery. An Israeli firm called UltraShape plans to fix that.
If ever a modality was all things to all people, that modality is ultrasound. Just about the only specialty these days not using a form of noninvasive ultrasound is plastic surgery. An Israeli firm called UltraShape plans to fix that.
The company has come up with an externally applied fat zapper, a high-intensity ultrasound system. The zapper blasts fat cells into oblivion while leaving surrounding structures such as skin, blood vessels, and nerves intact. If the popularity of Nip/Tuck and Dr. 90210 are any indication, this zapper is going to be big. Already the company has some deep-pocketed believers.
Last month UltraShape raised $15.1 million in new capital to further develop its body contouring technology. The Contour I system, available in selected markets including the European Union, has not yet received FDA clearance. But clearance is coming.
UltraShape has recruited some of the best connected plastic surgeons in the U.S. to serve on its North American Medical Advisory Board. These folks hail from Harvard, University of California, Los Angeles, the University of North Carolina at Chapel Hill, and Johns Hopkins University, to name a few.
En route to the world's number one market for medical devices, UltraShape has stopped off at 250 clinics in 46 countries to perform 30,000 "walk-in, walk-out" procedures. The privately held, venture-backed company has opened 26 offices in Europe, 10 in Asia-Pacific, eight in Latin America, and one each in Canada, the U.S., and Africa. To meet their goals, UltraShape's executives will need all the locations they can muster.
UltraShape seeks to redefine "aesthetic medicine," according to its corporate statement. In the process, it could redefine ultrasound. Nothing appeals to human nature from a medical perch more directly than this. Clearly, the ultrasound boutiques for prenatal photo albums and the baby heart monitors crafted from pocket Dopplers were, if you excuse the expression, little more than child's play
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.